KR20170025361A

KR20170025361A - Composition for improving skin

Info

Publication number: KR20170025361A
Application number: KR1020150121702A
Authority: KR
Inventors: 여혜린; 김도형; 김효진; 이상화
Original assignee: 주식회사 엘지생활건강
Priority date: 2015-08-28
Filing date: 2015-08-28
Publication date: 2017-03-08
Also published as: KR101872919B1

Abstract

The present invention relates to a composition for improving skin. According to the present invention, the flax seed extract according to the present invention can be used for skin regeneration, atopic improvement, skin moisturizing and skin texture improving effect by promoting proliferation of dermal stem cells, excellent effect of PPAR alpha, , Cosmetics or foods. In addition, it promotes the proliferation of dermal stem cells and exhibits a stem cell-retaining effect, and thus can be used for the production of a cosmetic for promoting stem cell activity.

Description

[Composition for improving skin]

The present invention relates to a skin improving composition showing skin regeneration, atopic improvement, skin moisturizing, skin texture improvement, and stem cell activity promoting effect.

The epidermis, located at the outermost part of the skin, has a protective function to protect against various external physical, chemical and mechanical stimuli and to prevent excessive divergence of body water through the skin. This protective function is possible by normally forming and maintaining the stratum corneum composed of keratinocytes. The keratinocyte is a cell formed by a stepwise change in morphology and function while a basal cell that continuously proliferates in the stratum basale moves to the stratum corneum, Forming cells are removed from the skin and the new keratinocytes from the epidermis's bottom layer repeat the process of epidermis differentiation or keratinization replacing its function. In this keratinization process, keratinocytes produce intercellular lipids such as natural moisturizing factors (NMF) and ceramides, cholesterol, and fatty acids, which act as barrier layers to the outside, As shown in Fig.

In addition, skin dryness, which is considered to be one of the major diseases of modern society, is one of symptoms caused by skin barrier function abnormality. Recently, environmental pollution, increase in dry environment such as apartments and high rise buildings, increase in social stress, Excessive bathing culture, skin aging, and the like, and it is also increasing steadily when the condition is serious and there is a need for treatment.

Atopic dermatitis, which is present in 10% of children in recent years, is also known to be a cause of dry skin syndrome, and more fundamentally, abnormal skin barrier function. In order to treat such atopic dermatitis, studies have been carried out in order to supply water from the outside or minimize water loss from the body by focusing on proper moisture retention in the skin in the past. Actually, ceramide or derivatives thereof have been developed and are widely used in the pharmaceutical or cosmetic field.

However, most of the use of such moisturizers is merely a temporary symptom relief rather than a fundamental treatment, and thus does not show sufficient effect for treatment of dry skin and skin barrier function including atopic dermatitis. Therefore, it is urgent to develop a substance that can restore the damaged skin barrier fundamentally.

Recently, it has been known that PPAR alpha (peroxisome proliferator activated receptor-alpha) present in keratinocyte cells is activated by binding to its ligand, thereby promoting the differentiation of keratinocytes and reconstructing damaged skin barrier. In the case of applying Clofibrate (Non-Patent Document 1) or WY 14643 (Non-Patent Document 2) which is an agonist of PPAR alpha actually known to the skin with damaged skin barrier, differentiation of keratinocytes is accelerated And recovery of the skin barrier is promoted.

In addition, the skin texture, which is the shape of the skin surface, is characterized by a three-dimensional microstructure formed by fine lines and is significantly different according to age and site. The skin texture is divided into primary (about 20-100 ㎛), secondary (about 5-40 ㎛), and tertiary (about 0.5 ㎛) lines depending on the depth of the line. And has a distinctive polygonal shape and star formation caused by the lines meeting [Non-Patent Document 3].

However, as the age increases or the skin becomes damaged, the network structure of the dense fine lines collapses and fine lines (secondary, tertiary, etc.) disappear and the primary lines become deeper and wrinkles are known to be produced Literature 4,5]. In other words, wrinkles, a typical sign of skin aging, are accumulations of minute changes that have already occurred over a long period of time.

Embryologically, all components of human skin are known to originate from ectoderm or mesodermal lobe. Epidermis, hair follicles, sebaceous glands and glands are originated from ectoderm, and melanocytes, nerves and special sensory receptors are derived from neuroepithelial cells. According to the developmental stage, the embryonic stem cells are repeatedly differentiated and become cells with the characteristics of each tissue function. After the embryo, a certain number of stem cells remain in the tissue. . The first is in the hair follicle. It is known to play an important role in the regeneration of the epidermis into cells before cell differentiation occurs, and plays an important role in hair regeneration and growth. The second is the basal layer of the epidermis. The stem cells found here play an important role in maintaining skin health by administering not only the epidermis but also the fibroblasts of the dermal layer. The stem cells here are relatively large in quantity and easy to obtain, making them widely used in the study of skin stem cells. The skin is constantly renewed, and stem cells present in the epithelium of the skin, that is, epidermal stem cells of the skin, are involved in the repair of the epithelium after injury [Non-Patent Document 6]. The epithelial stem cells of the skin are also referred to as skin stem cells. When the skin stem cells are activated, it is possible to treat skin wounds such as trauma, promote wound healing, have. Integrin β1 and integrin α6 are used as indicators of dermal stem cells, and maintenance of skin stem cells necessary for epithelial morphogenesis and differentiation has been reported to be regulated by p63 protein.

Dermal stem cells play an important role in maintaining the health and physiological and biochemical homeostasis of the skin. Stem cells present in the skin are also abnormally functioned due to the effect of aging, and thus various problems arise as the homeostasis of the skin is broken. Therefore, various phenomena of skin aging can be improved through the activation of stem cells [Non-Patent Document 7].

In addition, it is safe to use in the living body, the active ingredient is stable, and most of all, the skin regeneration, atopic improvement, skin moisturization and skin texture improving activity which are more effective than the substances having the skin regeneration, atopic improvement, skin moisturizing, It is urgently required to develop a component having an amino acid sequence.

On the other hand, it is said that the poppy enjoyed it, and it is also called the king of fruits in southern China. It is an evergreen tree with a height of 10 ~ 15m, which is a seedless seed. Also known as the English name litchi (lychee). The foliar fruit is oval or round, with a diameter of 3 ~ 4㎝ and a diameter of 2.5 ~ 3㎝. The fruit skin is swollen, and the surface has a scabbled pattern with a protruding center. The flesh is milky white and has a lot of moisture. It has a slightly acidic and sweet taste that harmonizes with the taste and has a unique direction. The fruit grows and grows well in the humid acid soil of the subtropical region. It grows widely in the tropics as a fruit of the origin of southern China.

The seedless seedless nucleus is elliptical-oval, one side is flattened and flat, 12-22mm in length and 6-16mm in diameter. Outer surface is dark red to black-white, smooth, glossy, wrinkled with a sparse, wrinkled at one end, dull, and relatively hard.

Nuclear waste has been used for symptoms such as colic, tinnitus, and abdominal pain, which relieve pain and relieve cold aura. The chemical components contained in the foliar nucleus include α- (methylenecyclopropyl) glycine, 3-acetoin, 2,3-butanediol, cobalt, copaene, cis-caryophyllene, allo-aromadendrene, humulene, delta -cadinene, alpha-curcumene, Calamenene, ledol, guaiazulene, xanthorrhizol, palmitic acid, and the like are known.

Despite the many human efficacy of this fleece nucleus, there is no research on the skin and stem cells of the fleece nucleus.

1. Feingold et al., J. Invest. Dermatol., 110, pp 368-375, 1998. 2. Feingold et al., J. Invest. Dermatol., 115, pp 353-360, 2000. 3. Journal of the European Academy of Dermatology and Venereology. 12: 103-114, 1999 4. The British journal of dermatology. 110: 129-138, 1984 5. Skin research and technology.5: 189-194, 1999 6. Epidermal Stem Cells of the Skin, Cedric Blanpain, Elaine Fuchs, Annual Review of Cell and Developmental Biology, November 2006, Vol. 22, Pages 339-373 7. Human skin stem cells and the aging process, Catherin Niemann, Stem Cell Aging and Regenerative Medicine, November 2008, Pages 986-997

Thus, the inventors of the present invention found that the fernaceae extract promotes the proliferation of dermal stem cells, promotes regeneration of skin, has excellent activity of PPAR alpha, has an atopic improvement effect, exhibits skin moisturizing effect due to an increase in fila green expression, The present invention has been accomplished by confirming the effect of promoting stem cell activity by promoting proliferation of skin stem cells and exhibiting stem cell maintenance effect in addition to skin texture improving effect due to brightness improvement.

Accordingly, an object of the present invention is to provide a composition for improving skin regeneration, atopic ecnomance, skin moisturization, and skin texture, which comprises a foliar nuclear extract as an active ingredient.

Another object of the present invention is to provide a composition for stimulating stem cell activity, which comprises a foliar nuclear extract as an active ingredient.

As a means for solving the above problems, the present invention provides a composition for skin regeneration, atopy improvement, skin moisturizing, and skin texture improvement, which comprises a flax seed extract as an active ingredient for the manufacture of medicines, cosmetics or foods.

As another means for solving the above-mentioned problems, the present invention provides a composition for promoting stem cell activity, which comprises a flax seed extract as an active ingredient, for the production of cosmetic formulations.

The present invention relates to a method for the treatment and prophylaxis of skin cancer, which comprises the steps of: (a) And can be used for the manufacture of medicines, cosmetics or foods.

In addition, the flax seed extract promotes the proliferation of dermal stem cells and exhibits a stem cell maintenance effect, and thus can be used for the production of a cosmetic formulation for promoting stem cell activity.

Hereinafter, the configuration of the present invention will be described in detail.

In order to exert an excellent effect when the skin regeneration, atopic improvement, skin moisturizing and skin texture improving effect are applied to the actual skin, it exhibits highly active skin regeneration, atopic improvement, skin moisturizing and skin texture improving activity, Is low in volatility so as to be able to stay for a sufficient time to exhibit skin regeneration, atopic improvement, skin moisturizing and skin texture improving effect and is capable of stably maintaining the active ingredient on the composition or skin, Etc., and it is preferable that it is safe for the skin. However, the components satisfying all of the above-mentioned characteristics among the known components are not common. For example, some skin regeneration, atopic improvement, skin moisturizing and skin tone improving ingredients are excellent in skin regeneration, atopic improvement, skin moisturizing and skin tone improving activity even at low concentration in in vitro test, It is difficult to apply to real skin. Other active ingredients have low hydrophilicity, making them difficult to formulate into medicines, cosmetics, and foods. In addition, some skin regeneration, atopic improvement, skin moisturizing and skin irritation improving ingredients may be degraded or transformed into other compounds when they are exposed to heat, light, or oxygen, .

As can be seen from the following examples, the fernaceae extract exhibits remarkably excellent proliferation promoting effect on skin stem cells, PPAR alpha activity, pilar green expression effect and skin brightness improvement at a low concentration. Therefore, skin regeneration, It may be used as an active ingredient of medicines, cosmetics or food compositions for moisturizing and improving skin texture.

Accordingly, the present invention provides a composition for improving skin regeneration, atopic improvement, skin moisturization and skin texture, which comprises a fernaceae extract as an active ingredient.

The flax seed extract may be extracted by a method known in the art, and the method is not particularly limited. Alternatively, commercially available extracts can be used.

Preferably, the foliar nuclear extract may be an extract obtained by extracting a fleece nucleus with water and / or an organic solvent. The organic solvent may be a polar organic solvent, a nonpolar organic solvent or a mixture thereof. The polar organic solvent may be a lower alcohol having 1 to 5 carbon atoms, ethyl acetate or acetone, and the nonpolar organic solvent may be ether, chloroform, benzene, hexane or dichloromethane. For example, the lower alcohol having 1 to 5 carbon atoms may be methanol, ethanol, propanol, butanol or isopropanol.

In one embodiment, the fernaceous nuclear extract may include a fraction obtained by fractionating the primary extract extracted using the above-described extraction solvent with an extraction solvent having a different polarity. For example, the fernaceous nuclear extract may be a fraction obtained by extracting with an alcohol having 1 to 5 carbon atoms and then fractionating again with a solvent having a different polarity such as ether, benzene or hexane. Two or more kinds of solvents may be used for the fractionation, and the solvent extracts may be sequentially used or mixed according to the polarity of the solvent.

In the present invention, the extracted extract or the fraction obtained by performing the fractionation process may be filtered, concentrated or dried to remove the solvent, and the filtration, concentration, and drying may all be performed. Specifically, the filtration can be performed using a filter paper or a vacuum filter, and the concentration can be reduced by using a reduced pressure concentrator or the like, and the freeze-drying method can be carried out for drying.

The fractions obtained by performing the above-described extract or the fractionation process can be further purified by silica gel column chromatography, thin layer chromatography or high performance liquid chromatography Further purification can be achieved by purification using various chromatographic techniques.

The compositions of the present invention may be used for the manufacture of pharmaceutical formulations.

The pharmaceutical formulations may be in the form of solutions, suspensions or emulsions in oils or aqueous media, or in the form of excipients, powders, granules, tablets or capsules.

In addition, the composition may further contain one or more active ingredients showing the same or similar functions. For example, it may contain known skin regeneration, atopic improvement, skin moisturizing and skin tone improving ingredients. The skin regeneration, atopic improvement, skin moisturizing and skin texture improving effect of the composition of the present invention may be further enhanced if the skin regeneration, atopic improvement, skin moisturization and skin texture improving ingredient are included. When the above ingredients are added, skin safety, easiness of formulation, and stability of effective ingredients can be considered according to the combined use. In one embodiment of the present invention, the composition is a skin regeneration component known in the art comprising retinoic acid, TGF, protein from animal placenta, betulinic acid and chlorella extract, antioxidant components known in the art, such as tocopherol, selenium , Vitamin C and phenolic compounds, whitening ingredients known in the art, substances inhibiting the activity of tyrosinase enzymes such as kojic acid and arbutin, hydroquinone, vitamin C (L- Ascorbic acid, derivatives thereof, and various plant extracts. The additional components may be contained in an amount of 0.0001 to 10% by weight based on the total weight of the composition, and the content may be adjusted according to requirements such as skin safety, ease of formulation of the fernaceous nuclear extract, and the like.

In addition, the composition of the present invention may further comprise a pharmaceutically acceptable carrier.

Pharmaceutically acceptable carriers may contain a variety of ingredients such as buffer, injectable sterile water, normal saline or phosphate buffered saline, sucrose, histidine, salts and polysorbates, and the like.

The composition of the present invention can be administered orally or parenterally, and can be administered in the form of a general pharmaceutical preparation, for example, various forms of oral and parenteral administration at the time of clinical administration. In the case of formulation, a filler, , A binder, a wetting agent, a disintegrant, a surfactant, and the like.

Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like. These solid preparations can be prepared by mixing the pharmaceutical composition of the present invention with at least one excipient such as starch, calcium carbonate, Sucrose, lactose, gelatin and the like can be prepared.

In addition to simple excipients, lubricants such as magnesium stearate talc are also used. Examples of liquid formulations for oral administration include suspensions, solutions, emulsions, syrups and the like. Various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included in addition to water and liquid paraffin, which are simple diluents commonly used.

Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like can be used as the non-aqueous solvent and suspension agent. Examples of the suppository base include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.

In the present invention, the term " skin regeneration effect " refers to restoration of skin tissue against damage caused by external or internal causes of the skin. Damage due to external causes may include ultraviolet rays, external contaminants, wound, trauma, etc. The damage caused by the internal causes may be stress.

In the present invention, the term 'atopic improvement effect' refers to the effect of preventing and treating skin diseases such as atopy and dry skin, and is to inhibit, inhibit, or alleviate atopic symptoms.

In the present invention, the term 'moisturizing effect' refers to inhibiting or reducing the reduction of moisture in the skin, or increasing the moisture content of the skin to smooth and smooth the surface of the skin.

In the present invention, the term " skin texture improving effect " refers to smoothing the skin surface, imparting gloss, and brightening the skin tone by inhibiting or inhibiting roughness of the skin surface due to aging, stress, .

In the present invention, the term "effective amount" means an amount of the extract capable of promoting regeneration of damaged skin, improving dry skin such as atopy, or improving moisturizing effect and skin texture. When the composition of the present invention contains an effective amount of the fernaceous nuclear extract, it is possible to provide a desirable skin regeneration effect, atopic improvement effect, moisturizing effect and skin texture improving effect. The effective amount of the flax seed extract contained in the composition of the present invention will vary depending on the form in which the composition is commercialized, the method in which the compound is applied to the skin, and the time on the skin. For example, when the composition is commercialized in a pharmaceutical formulation, it may contain a high concentration of the flax seed extract as compared with the case where it is commercialized as cosmetics to be applied to skin on a daily basis. Accordingly, the daily dosage is 0.1 to 100 mg / kg, preferably 30 to 80 mg / kg, more preferably 50 to 60 mg / kg, and 1 to 6 mg / kg per day based on the amount of the above- &Lt; / RTI >

The composition of the present invention may be used alone or in combination with methods using surgery, radiation therapy, hormone therapy, chemotherapy, and biological response modifiers.

The pharmaceutical formulations of the present invention may include external preparation for skin.

In the case of using the flax seed extract as an external preparation for skin, it is further possible to use a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, For example, water, ionic or nonionic emulsifiers, fillers, sequestering agents and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or external preparations for skin And any other ingredients used, such as those commonly used in the field of dermatology. The components can also be introduced in amounts commonly used in the field of dermatology.

When the flax seed extract is provided as an external dermal preparation, it may have a formulation such as, but not limited to, ointments, patches, gels, creams or sprays.

Furthermore, the composition for skin regeneration, atopic improvement, skin moisturizing and skin texture improvement of the present invention can be used for the production of cosmetic formulations.

The cosmetic formulation may be in the form of a conventional emulsion formulation and a solubilized formulation. For example, creams, essences, cosmetic creams, sprays, gels, packs, sunscreens, make-up bases, liquids such as lotions such as lotion, facial lotion, body lotion, A powder, a cleansing lotion, a makeup removing agent such as a cleansing oil, a cleansing foam, a soap, a body wash, and the like.

In addition, the cosmetic composition may further comprise at least one selected from the group consisting of fatty substances, organic solvents, solubilizers, thickeners and gelling agents, softeners, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, As used herein means any emulsion or emulsion which is commonly used in emulsifying or emulsifying agents, fillers, sequestering and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics Adjuvants commonly used in the cosmetics field, such as other ingredients.

The cosmetic formulation may contain a relatively high concentration of the flaxseed extract in the case of a wash-off type cosmetic such as a make-up remover, a detergent, etc. in which the active ingredient remains on the skin in a short period of time. On the other hand, in the case of leave-on type cosmetics such as lotion, cream, essence and the like in which the active ingredient remains on the skin for a long period of time, It may be possible. In one embodiment of the present invention, but not limited thereto, the composition may comprise from 0.0001% to 10% by weight (preferably 0.0001% to 1% by weight) of the follicular nucleus extract relative to the total composition weight have. If the composition of the present invention contains less than 0.0001% by weight of the fernaceous nuclear extract, sufficient skin regeneration, atopic improvement, skin moisturizing and skin texture improving effect can not be expected. If the composition contains more than 10% by weight, This is to prevent unwanted reactions or skin safety problems.

Furthermore, the composition for skin regeneration, atopic improvement, skin moisturizing and skin texture improvement of the present invention can be used for manufacturing food formulations.

The food formulation refers to a food prepared by adding the above-described fernaceae extract to a food material such as a beverage, a tea, a spice, a gum, confectionery, or the like, or encapsulating, pulverizing or suspending.

Since the food preparation can be ingested routinely, it is very useful because high skin regeneration, atopic improvement, skin moisturizing and skin texture improving effect can be expected.

When the fernaceut extract is used as a food additive, the fernacept extract may be directly added or used together with other food or food ingredients, and may be suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to its intended use (prevention, health or therapeutic treatment). Generally, the composition of the present invention is added in an amount of not more than 15 parts by weight, preferably not more than 10 parts by weight, based on the raw material, when the food or beverage is produced. However, in the case of long-term consumption intended for health and hygiene purposes or for health control purposes, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range .

There is no particular limitation on the kind of the food. Examples of foods to which the above substances can be added include dairy products including meats, sausages, breads, chocolates, candies, snacks, confections, pizza, ramen noodles, gums, ice cream, soups, drinks, tea, Alcoholic beverages, and vitamin complexes, all of which include health foods in a conventional sense.

When the food is a beverage, various flavors or natural carbohydrates may be added as an additional ingredient such as a normal drink. The above-mentioned natural carbohydrates are sugar alcohols such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 mL of the composition of the present invention.

In addition to the above, the food formulations may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, And the like. Other food formulations may contain flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not critical, but is generally selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.

The present invention also provides a composition for promoting stem cell activity comprising the above-mentioned fernaceae extract as an active ingredient.

The term 'stem cell' in the present invention is a cell capable of cell division by itself and capable of differentiating into a very specific type of specific cell type. The type of such stem cells is not particularly limited, and in one embodiment, the stem cells may be dermal stem cells. The term 'dermal stem cells' refers to stem cells that can be differentiated into cells constituting the skin (epidermis, dermis and subcutaneous fat layer). The cells that make up the skin include keratinocytes, melanocytes, and fibroblasts (mainly responsible for biosynthesis of collagen and elastin) present in the epidermis.

The kind of the skin stem cell is not particularly limited. The dermal stem cells used in the present invention can be used irrespective of where they originate from. For example, dermal stem cells may be obtained from a known source of dermal stem cells, e. G., From the basal layer of hair follicles or epidermis, and the animal to be harvested may be a mammal. In one embodiment, the mammal may include, but is not limited to, a human, a mouse, a rat, a guinea pig, a rabbit, a monkey, a pig, a horse, a cattle, a sheep, Preferably the mammal can be human. Such methods of obtaining dermal stem cells from dermal stem cell sources are well known in the art.

In the present invention, the term 'promoting effect on stem cell activity' refers to an effect of promoting stem cell proliferation and / or an effect of maintaining stem cell characteristics, which is a specific indicator molecule and a self-cleaving property of stem cells.

In addition, the compositions of the present invention can be used for the production of cosmetic formulations. These cosmetic formulations are the same as those described in the description of cosmetic formulations including the above-mentioned wormwood extract.

Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.

Manufacturing example One: A waste nucleus Preparation of extract

The lignin nuclei were washed and pulverized, and then cooled with 10 times of ethanol (w / v) for 5 days. The extract solution was filtered and concentrated to obtain an extract. To this was added a mixed solution of purified water and ethanol to dissolve and then filtered to prepare a final extract.

Manufacturing example 2: Serum-free Under medium conditions Of dermal stem cells culture

Human epidermal stem cells purchased from Cellntec were added to a 96-well plate (5 x 10 ³ cells / well) supplemented with BPE (bovine pituitary extract) similar to fetal bovine serum And cultured for 24 hours at 5% CO ₂ and 37 ° C using CNT-57 medium (Cellntec). Thereafter, the culture medium was removed through a suction tube, and then the medium was removed using a PBS solution (GibcoBRL). 5 CO CO ₂ and 5 쨉 g / ml of bare nucleus extract were treated with CNT-57 medium containing no BPE And cultured at 37 ° C for 72 hours.

Experimental Example One: CCK -8 Through evaluation method Dermal stem cells Proliferation promoting effect

The skin stem cells cultured in Preparation Example 2 were evaluated for CCK-8 (Cell counting kit-8). The CCK-8 assay is an indirect method of measuring the density of living cells by measuring the absorbance of Formazan, a dehydrogenase in the intracellular electron transport system, produced by the decomposition of tetrazolium salt.

Cells were treated spectrophotometrically by treating CCK-8 solution (treated with 1/10 of the medium volume) at 37 ° C for 2 hours and then measuring the absorbance at 450 nm. From the measured absorbance values, the proliferation rate (%) of the skin extract of the fernaceae extract was determined by the following equation (1) against the control group (CNT-57 medium without extract) .

[Equation 1]

Growth rate (%) = (absorbance of sample-treated group / absorbance of control group) x 100

Promoting the proliferation of skin stem cells (number of repetitions = 3) Additive sample density Cell proliferation (%) versus control Leaf Nuclear Extract 5 / / ml 152% Control group - 100%

As shown in Table 1, the skin stem cells in the media condition treated with the nuclear extract of the fleece showed an excellent proliferation promoting effect.

Experimental Example 2: Of dermal stem cells Stem cell ( stemness ) Confirm maintenance effect

The expression level of p63 was evaluated in order to confirm the stem cell maintenance effect of the dermal stem cells cultured in Production Example 2 above. p63 is an intracellular transcription factor and is well known as a maintenance marker for dermal stem cells. Cells were isolated and cDNA was synthesized. Then, real-PCR was performed with Taqman staining solution to measure the expression level of p63. The concentration of RNA in this experiment was normalized to S16 ribosomal RNA.

The experimental results are shown in Table 2 below. In Table 2 below, the numerical value of the increase in p63 is a multiple of the control group (CNT-57 medium supplemented with BPE).

Stem cell (stem cell) maintenance effect (number of repeats = 3) Additive sample density p63 Incremental multiple (times) Leaf Nuclear Extract 5 / / mL 1.85 Control group - 1.0

As shown in Table 2, the medium conditions treated with the nuclear extract of the fleece promoted the expression of p63 in the dermal stem cells, and thus the stem cell maintenance effect was excellent.

Example One: PPAR Verification of Alpha Activation Promotion Effect

In order to confirm the promoting effect of PPAR alpha activation of the flax seed extract, the following experiment was performed using a fernaceae extract. C2C12 cells (ATCC CRL-1772), a mouse myoblast cell line, were subcultured in DMEM (Dulbecco's Modified Eagle's Medium) medium containing 10% fetal bovine serum. As the vector used herein,

1) A DNA fragment encoding GAL4-DBD (DNA Binding Domain), which is a transcription factor of yeast, and Ser ₁₆₇ to Tyr ₄₆₈ in human PPAR alpha LBD (Ligand Binding Domain), into a SV40 promoter of pZEO vector (Invitrogen) NM 005036);

2) the GAL4 response sequence is inserted into the multiple restriction enzyme recognition site of pGL3 vector (Promega) expressing luciferase, and

3) A vector expressing? -Galactodisase as a transfection internal control was used.

The cultured cells were plated on a 24-well plate at 4 × 10 ⁴ cells and cultured for 12 hours. The three types of plasmid genes were transiently transfected using lipopectamine. After 8 hours, the flax seed extract was diluted and cultured for 12 hours, washed with 1? PBS, lysed with 1 × reporter lysis buffer, and luciferase assay kit (Promega) And [beta] -galactosidase assay kit (Promega) were used to measure the activity of luciferase. That is, the PPAR alpha activity was measured as " luciferase activity / beta -galactose activity ".

Wy-14,643 (Calbiochem), the most potent ligand of PPAR alpha, was used as a positive control in this experiment, and DMSO 0.05% was used as a negative control.

According to the above experimental method, the activity of PPAR alpha was measured according to the concentration by treating the cryopreserved nuclear extract with C2C12 cells. The results are shown in Table 3 below. In Table 3 below, the value of PPAR alpha activity refers to the percentage of negative control (0.05% DMSO).

Activity of PPAR alpha sample PPAR alpha activity (%) DMSO (0.05%) 100 Wy-14,643 (0.5 [mu] M) 324 Wy-14,643 (1 [mu] M) 928 Leaf Nuclear Extract (0.05%) 502 Leaf Nuclear Extract (0.5%) 920

As shown in Table 3, it was confirmed that, compared to the positive control group, the wilted nuclear extract showed a very strong PPAR alpha activity.

Example 2: Filaggrin's Promoting effect of expression

The cells were cultured for 1 day, and then the RNAs of the cells were separated, and cDNA was synthesized. Then, the Taqman stain solution was used for Real -time PCR was performed. The RNA concentration was normalized to S16 ribosomal RNA.

Effect of expression of pillar green depending on concentration (number of repeats = 3) Additive sample Increase in pillar green compared to control Control group (no addition) 1.00 Leek seed extract (5 ㎍ / ml) 26.7 Leek seed extract (10 ㎍ / ml) 53.5

As shown in Table 4, the flax seed extract has the ability to promote pilar green expression of human keratinocyte HaCaT cells.

Example 3: To improve the turn-over of the skin About Efficacy

About the nutritional cream of the following formulation example 2, the effect of the improvement of the exfoliation of the skin in the healthy twenties to 50 women was tested as follows.

Twenty test tubes of 20 women aged 20 to 50 years were coated with 1.5% solution of DHA (Dihydroxyacetone, Sigma Aldrich, USA) for 8 hours, and then the nutritional cream of Preparation Example 2 was applied to the test site twice daily . After 4 days of application, 8 days after application, 12 days after application, photographs were taken using instrument Chromameter CR-400 (Minolta, Japan) and skin lightness of DSLR and DSLR. The measured values were evaluated by three mean values excluding the maximum value and the minimum value. The higher the improvement in the skin brightness of the deposition site, the better the improvement of the exfoliation. The results are shown in Table 5 below.

Skin brightness improvement effect division Four days after application Eight days after application After 12 days of application Improvement rate (%) 1.95 6.23 13.59

As shown in Table 5, when the nutritional cream according to the present invention was used, it was found that the exfoliation of the skin was improved.

Formulation example 1: Manufacture of pharmaceutical preparations

1. Preparation of tablets

Leaf Nuclear Extract 0.2 mg

100 mg of corn starch

100 mg of milk

2 mg of magnesium stearate

After mixing the above components, tablets were prepared by tableting according to a conventional method for producing tablets.

Formulation example 2: Manufacture of cosmetics

1. Manufacture of nutritional cream

As in the following composition, a nutritional cream containing a fleece extract as an active ingredient was prepared according to a conventional method.

0.2% w / w nuclear extract

Beta-1,3-glucan 5.0 wt%

Wax 10.0 wt%

Polysorbate 60 1.5 wt%

&Lt; tb > < tb > < tb >

0.5% by weight of sorbitan sesquioleate

Liquid paraffin 10.0 wt%

Squalane 5.0 wt%

Caprylic / capric triglyceride 5.0 wt%

Glycerin 5.0 wt%

3.0% by weight of butylene glycol

3.0% by weight of propylene glycol

0.2% by weight triethanolamine

Preservative 0.05 wt%

0.05% by weight of pigment

0.05% by weight fragrance

Purified water to 100%

Formulation example 3: Preparation of external preparation for skin

1. Manufacture of ointment

As in the following composition, an ointment containing a fleece extract as an active ingredient was prepared by a conventional method.

Leaf Nuclear Extract 0.5 wt%

Beta-1,3-glucan 10.0 wt%

Wax 10.0 wt%

Polysorbate 60 5.0 wt%

&Lt; tb > < tb > < tb >

0.5% by weight of sorbitan sesquioleate

Vaseline 5.0 wt%

Liquid paraffin 10.0 wt%

Squalane 5.0 wt%

SHARE BUTTER 3.0 wt%

Caprylic / capric triglyceride 5.0 wt%

Glycerin 10.0 wt%

Propylene glycol 10.2 wt%

0.2% by weight triethanolamine

Preservative 0.05 wt%

0.05% by weight of pigment

0.05% by weight fragrance

Purified water to 100%

Claims

A composition for skin regeneration comprising a fleece nuclear extract as an active ingredient.

The method according to claim 1,
The present invention relates to a composition for skin regeneration, which is an extract obtained by extracting a fleece nucleus with at least one selected from the group consisting of water and an organic solvent.

3. The method of claim 2,
The organic solvent may be a polar solvent containing a lower alcohol having 1 to 5 carbon atoms, ethyl acetate, or acetone; A nonpolar solvent comprising ether, chloroform, benzene, hexane or dichlorohexane; Or a mixed solvent thereof.

The method according to claim 1,
Wherein the composition is for the manufacture of a medicament for skin regeneration, a cosmetic preparation or a food product.

A composition for improving atopy comprising an extract of a fleece nucleus as an active ingredient.

6. The method of claim 5,
Wherein the composition is for the manufacture of a medicament for the improvement of atopy, a cosmetic preparation or a food product.

A composition for moisturizing the skin comprising a fernaceous nuclear extract as an active ingredient.

8. The method of claim 7,
Wherein the composition is for skin moisturizing medicines, cosmetics or foods.

A composition for improving skin texture comprising an extract of a fleece nucleus as an active ingredient.

10. The method of claim 9,
Wherein the composition is for the manufacture of a medicament for the improvement of skin texture, a cosmetic preparation or a food product.

A composition for accelerating stem cell activity comprising a foliar nuclear extract as an active ingredient.

12. The method of claim 11,
Wherein the composition is for promoting stem cell proliferation or stem cell retention.

12. The method of claim 11,
Wherein the composition is for the production of a cosmetic for promoting stem cell activity.